Feedback / Questions
ILX-002 - Illexcor Therapeutics
https://www.prnewswire.com/news-releases/zynext-ventures-invests-in-illexcor-therapeutics-to-advance-novel-oral-therapy-for-sickle-cell-disease-302400164.html
Mar 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next